Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Predictors of treatment-response to acute prescription medications in migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study.

< BACK TO ARCHIVE


Papers: 12 Nov 2022 - 18 Nov 2022

PAIN TYPE:
Migraine/Headache


2022 Nov 03


Clin Neurol Neurosurg


http://www.ncbi.nlm.nih.gov/pubmed/36395587?dopt=Abstract


223

Predictors of treatment-response to acute prescription medications in migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study.

Authors

Predictors of treatment-response to acute prescription medications in migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
Ezzati A, Buse DC, Fanning KM, Reed ML, Martin VT, Lipton RB
Clin Neurol Neurosurg. 2022 Nov 03; 223:107511.
PMID: 36395587.

Abstract

To identify predictors of acute treatment optimization with prescription drugs among people with episodic migraine.
Read This Paper